Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme regulating folate metabolism, which affects DNA synthesis and methylation. This study investigated the relation of MTHFR C677T and A1298C polymorphisms to colorectal cancer in a case-control study in Fukuoka, Japan. The subjects comprised 685 incident cases of histologically confirmed colorectal adenocarcinomas and 778 community controls selected randomly in the study area. The genotype was determined by the PCR-RFLP method using genomic DNA extracted from buffy coat. Alcohol use was ascertained by in-person interview. Statistical adjustment was made for gender, age class, area, and alcohol use. The MTHFR 677TT genotype was associated with a statistically significant decrease in the risk with an adjusted odds ratio of 0.69 (95% confidence interval 0.51-0.93) compared with the 677CC and 677CT combined, and the decrease was most evident in individuals with no alcohol consumption. While the A1298C polymorphism showed no measurable association with the overall risk of colorectal cancer, the 1298CC genotype was associated with a statistically significant increase in the risk when alcohol consumption was high, and was also associated with an approximately 2-fold increase in the risk of each of proximal and distal colon cancer. The findings add to evidence that individuals with the MTHFR 677TT genotype have a decreased risk of colorectal cancer in the absence of folate depletion, suggesting a protective role of folate by ensuring a sufficient thymidylate pool for DNA synthesis. Because very few individuals had the 1298CC genotype, the findings regarding the A1298C polymorphism need careful interpretation and confirmation in larger studies. uch attention has recently been drawn to the role of folate metabolism in colorectal carcinogenesis.1, 2) Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme regulating folate metabolism. It irreversibly converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, which is the major form of folate in blood.2) The substrate of MTHFR, 5,10-methylenetetrahydrofolate, is required for conversion of deoxyuridylate to thymidylate. Depletion of 5,10-methylenetetrahydrofolate results in uracil misincorporation into DNA, and removal of this abnormal base may lead to single and double strand breaks.3, 4) Furthermore, insufficient thymidylate can increase DNA misrepair, resulting in overall DNA damage in the cell.5) On the other hand, 5-methyltetrahydrofolate provides the methyl group for methylation of homocysteine to methionine. Imbalanced DNA methylation, i.e., global genomic hypomethylation and methylation of usually unmethylated CpG sites, has been implicated in colorectal carcinogenesis. [6][7][8] Two common functional polymorphisms are known in the MTHFR gene; one is the C677T polymorphism in exon 4, resulting in an alanine-to-valine substitution at codon 222, 9) and the other is the A1298C in exon 7, resulting in a substitution of glutamate with alanine at codon 429.10) Individuals who are homozygous for the vari...